Self-management of immunomodulatory drug treatment in multiple myeloma patients.

Amélie CransacSerge AhoEdouard CosmeMarie-Lorraine ChretienCamille FavennecLaure SchrederMérédith BoutetPauline GueneauMaurice GiroudDenis CaillotMathieu Boulin

Published in: European journal of cancer care (2020)

The questionnaire has shown to be a valid tool for the assessment of the adherence and side-effect management skills for MM patients with IMID treatment.

Keyphrases

end stage renal disease
multiple myeloma
newly diagnosed
chronic kidney disease
emergency department
type diabetes
skeletal muscle
cross sectional
adverse drug
patient reported
weight loss
insulin resistance
electronic health record